Effects of overexpression of IL-10, IL-12, TGF-β and IL-4 on allergen induced change in bronchial responsiveness

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Fu, Chi Ling ^a   Ye, Yi Ling ^a   Lee, Yueh Lun ^b   Chiang, Bor Luen ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPID; LIPOFECTAMINE; OVALBUMIN; PLASMID DNA; PLASMID VECTOR; TRANSFORMING GROWTH FACTOR BETA; BETA CHEMOKINE; EOTAXIN; LEUKOTRIENE B4;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; GENE DELIVERY SYSTEM; GENE OVEREXPRESSION; GENE TRANSFER; LUNG LAVAGE; MOUSE; NEBULIZATION; NEUTROPHIL COUNT; NONHUMAN; PERITONEUM; PLASMID; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; TRACHEA; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DISEASE MODEL; GENETICS; INHALATION TEST; LOEFFLER PNEUMONIA; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES, CC; DISEASE MODELS, ANIMAL; FEMALE; GENE TRANSFER TECHNIQUES; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LEUKOTRIENE B4; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY EOSINOPHILIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745217889     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-72     Document Type: Article

References (60)

1. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB: Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326:298-304.
2. Umetsu DT, DeKruyff RH: Th1 and Th2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997, 100:1-6.
3. Wills-Karp M: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999, 17:255-281.
4. Jirapongsananuruk O, Leung DY: Clinical applications of cytokines: new direction in the therapy of atopic diseases. Annu Allergy Asthma Immunol 1997, 79:5-20.
5. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995, 182:1527-1536.
6. Hofstra CL, Van Ark I, Hofman G, Kool M, Nijkamp FP, Van Oosterhount A: Prevention of Th2-like cell responses by coadminstration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 1998, 161:5054-5060.
7. Brusselle GG, Kips JC, Peleman RA, Joos GF, Devos RR, Tavernier JH, Pauwels RA: Role of IFN-γ in the inhibition of allergic airway inflammation caused by IL-12. Am J Respir Cell Mol Biol 1997, 17:767-771.
8. Li XM, Chopra RK, Chou TY, Schofield BH, Wills-Karp M, Huang SK: Mucosal IFN-a gene transfer inhibits pulmonary allergic responses in mice. J Immunol 1996, 157:3216-3219.
9. Hogan SP, Foster PS, Tan X, Ramsay AJ: Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur J Immunol 1998, 28:413-423.
10. Dow SW, Schwarze J, Heath TD, Potter TA, Gelfand EW: Systemic and local interferon γ gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. Human Gene Ther 1999, 10:1905-1914.
11. Lee YL, Ye YL, Yu CI, Wu YL, Lai YL, Ku PH, Hong RL, Chiang BL: Construction of single-chain interleukin-12 DNA plasmid to treat airway hypersponsiveness in animal model of asthma. Human Gene Ther 2001, 12:2065-2079.
12. Barnes PJ: Cytokine-directed therapies for asthma. J Allergy Clin Immunol 2001, 108:S72-S76.
13. Nakao A: Is TGF-ΒI the key to suppression of human asthma? Trend Immunol 2001, 22:115-118.
14. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S: Interleukin- 10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996, 97:1288-1296.
15. John M, Lim S, Seybold J, Jose P, Robichaud A, O'Connor B, Barnes PJ, Chung KF: Inhaled corticosteroids increase interleukin- 10 but reduce macrophage inflammatory protein-1 α, granulocyte-macrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998, 157:256-262.
16. Wahl SM, Hunt DA, Wong HL, Dougherty S, McCartney-Francis N, Wahl LM, Ellingsworth L, Schmidt JA, Hall G, Roberts AB: Transforming growth factor beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 1988, 140:3026-3032.
17. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA Jr: Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med 1987, 166:571-576.
18. Brandes ME, Allen JB, Ogawa Y, Wahl SM: Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991, 87:1108-1113.
19. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ: Protective effect of transforming growth factor beta I on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991, 88:2918-2921.
20. Weiner HL: Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 1997, 48:341-351.
21. Hansen G, McIntire JJ, Yeung VP, Berry G, Thorbecke GJ, Chen L, DeKruyff RH, Umetsu DT: CD4+ T helper cells engineered to produce latent TGF-βI reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000, 105:61-70.
22. Oh J-W, Seroogy CM, Meyer EH, Akbari O, Berry G, Fathman G, DeKruyff RH, Umetsu DT: CD4+ T helper cells engineered to produce latent IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol 2002, 110:460-468.
23. Taube C, Dakhama A, Gelfand EW: Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allergy Immunol 2004, 135:173-186.
24. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ: The chemokines, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commum 1993, 197:1167-1172.
25. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD: Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 1996, 2:334-348.
26. Funk CD: Prostaglandins and leukotrienes: advances in eicosanoids biology. Science 2001, 294:1871-1875.
27. Lee YL, Tao MH, Chow YH, Chiang BL: Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy. Hum Gene Ther 1998, 9:457-465.
28. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsern GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997, 156:766-775.
29. Ye YL, Huang WC, Lee YL, Chiang BL: Interleukin-12 inhibits eotaxin secretion of cultured primary lung cells and alleviates airway inflammation in vivo. Cytokine 2002, 9:76-84.
30. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin-10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J Exp Med 1993, 178:1041-1048.
31. Lee YL, Fu CL, Ye YL, Chiang BL: Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation. Scand J Immunol 1999, 49:229-236.
32. Lee YL, Ye YL, Yu CI, Wu YL, Lai YL, Ku PH, Hong RL, Chiang BL: Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma. Human Gene Ther 2001, 12:2065-2079.
33. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA: Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci 1992, 89:7375-7379.
34. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGF-mediated oral tolerance. J Exp Med 1996, 183:2605-2616.
35. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
36. Kobayashi T, Iijima K, Kita H: Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 2003, 170:5756-5763.
37. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989, 170:2081-2095.
38. Borish L: IL-10: evolving concepts. J Allergy Clin Immunol 1998, 101:293-297.
39. Tournoy KG, Kips JC, Pauwels RA: Endogenous interleukin-10 suppresses allergen-induced airway inflammation and non-specific airway responsiveness. Clin Exp Allergy 2000, 30:775-783.
40. Justice JP, Shibata Y, Sur S, Mustafa J, Fan M, Van Scott MR: IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/ 6 mice. Am J Physiol Lung Cell Mol Physiol 2001, 280:L363-L368.
41. Yang X, Wang S, Fan Y, Han X: IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur J Immunol 2000, 30:382-91.
42. Makela MJ, Kanehiro A, Borish L, Dakhama A, Loader J, Joetham A, Xing Z, Jordana M, Larsen GL, Gelfand EW: IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammatory after allergic sensitization. Proc Natl Acad Sci USA 2000, 97:6007-6012.
43. Akdis CA, Blesken T, Akidis M, Wuthrich B, Blaser K: Role of interleukin 10 is specific immunotherapy. J Clin Invest 1998, 102:98-106.
44. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001, 2:725-731.
45. Tsitoura DC, DeKruyff RH, Lamb JR, Umetsu DT: Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J Immunol 1999, 163:2592-2600.
46. Collins PD, Marleau S, Griffiths-johnson DA, Jose PJ, Williams TJ: Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995, 182:1169-74.
47. Rothenberg ME: Eotaxin: An essential mediator of eosinophil traffficking into mucosal tissues. Am J Respir Cell Mol Biol 1999, 21:291-5.
48. Busse WW: Leukotrienes and inflammation. Am J Respir Crit Care Med 1998, 157:S210-S213.
49. Lewis SA, Austen KF, Soberman RJ: Leukotrienes and other products of the 5-LO pathway, biochemistry and relation to the pathobiology in human diseases. N Engl J Med 1990, 323:645-655.
50. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML: IL-12- deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naïve T helper cells. J Immunol 1997, 159:28-35.
51. Demeure CE, Yang LP, Desjardins C, Raynauld P, Delespesse G: Prostaglandin E2 primes naïve T cells for the production of anti-inflammatory cytokines. Eur J Immunol 1997, 27:3526-3531.
52. Mellio E, Woolley KL, Mannig PJ, Watson RM, O'Byrne P: Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994, 149:1138-1141.
53. Szczeklik A, Mastalerz L, Nizanokowska E, Cmiel A: Protective and brochodilatator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med 1996, 153:567-571.
54. Harizi H, Juzan M, Moreau J-F, Gualde N: Prostaglandins inhibit 5-lipoxygenase- activating protein expression and leukotriene B4 production from dendritic cells via IL-10-dependent mechanism. J Immunol 2002, 169:139-146.
55. Zuany-Amorim C, Haile S, Leduc D, Dumarey C, Huerre M, Vargaftig B, Pretolani M: Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995, 95:2644-2651.
56. van Scott MR, Justice JP, Bradfield JF, Enright E, Sigounas A, Sur S: IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am J Physiol Lung Cell Mol Physiol 2000, 278:L667-L674.
57. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin- 10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
58. Asadullah K, Sterry W, Volk HD: Interleukin-10 therapy: review of a new approach. Pharmacol Rev 2003, 55:241-269.
59. Nakagome K, Dohi M, Okunishi K, Komagata Y, Nagatani K, Tanaka R, Miyazaki J, Yamamoto: In Vivo IL-10 Gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J Immunol 2005, 174:6955-6966.
60. Behera AK, Kumar M, Lockey RF, Mohapatra SS: Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signalling Hum Gene Ther 2002, 157:3216-3219.